Furthermore, AR knockdown in urotehlial cells by intravesical instillation of antisense oligonucleotides, as shown with those of heat shock protein 27 in BC [21], is a potential treatment option to avoid systemic adverse effects associated with ADT currently used for the treatment of prostate cancer. This evidence concerns the gene AR and prostate cancer.